Bio Green Med Solution, Inc.

BGMS

Bio Green Med Solution, Inc.

BGMS

Insider Sentiment (TTM):

Last Purchase:2023-12-21Last Sale:2025-11-05Shares Purchased (TTM):0Shares Sold (TTM):1,603,615

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:118,543Shares Outstanding:5,458,564Institutional Ownership Pct.:2.17%

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Series B Preferred Stock	-	-	-	-	-	0	0	-0	0	0	0	0
Cash And Cash Equivalents At Carrying Value	3	4	4	4	3	3	3	6	3	3	6	10
Inventory Net	1	1	1	-	-	-	-	-	-	-	-	-
Accounts Receivable Net Current	1	1	1	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	0	0	1	0	0	1	2	2	2	4	5	5
Assets Current	6	6	6	4	4	4	5	8	5	7	11	15
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill	2	2	1,570	-	-	-	-	-	-	-	-	-
Deposits Assets Noncurrent	0	-	-	-	-	0	0	0	1	1	1	1
Assets	8	8	8	4	4	4	5	8	6	9	12	16
Liabilities Current
Liabilities And Stockhold…
Liabilities
Accounts Payable Current	0	1	0	0	0	5	4	5	5	4	2	2
Accrued Liabilities Current	1	1	1	1	1	2	2	2	3	5	7	5
Liabilities Current	1	1	1	1	1	6	6	7	8	8	8	7
Operating Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	-	-	-	-	-	-	-	-	-
Liabilities	1	1	1	1	1	6	6	7	8	8	8	7
Stockholders Equity
Preferred Stock Value	-	-	-	-	-	-	-	-	-	-	0	-
Temporary Equity Carrying Amount Including Portion…	-	-	-	-	-	-	-	-	-	0	0	4
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	461	461	451	445	443	438	437	436	430	430	428	424
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-	-	-	-1	-1	-1	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-455	-454	-444	-442	-440	-439	-436	-434	-431	-428	-423	-417
Convertible Preferred Stock	-	-	-	-	-	0	0	0	0	0	0	0
Stockholders Equity	7	7	7	4	3	-2	-1	1	-2	1	4	7
Liabilities And Stockholders Equity	8	8	8	4	4	4	5	8	6	9	12	16
Series A Preferred Stock	-	-	-	-	-	0	0	0	0	0	0	0
Allowance For Doubtful Accounts Receivable Current	0	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Dividend Rate Percentage	0	0	0	-	0	0	0	0	0	0	-	-
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	-	-	-	0.001	0.001	0.001
Temporary Equity Shares Issued	-	-	-	-	-	-	-	-	-	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	0	0	0
Common Stock Shares Authorized	600	600	600	600	250	100	100	100	100	100	100	100
Common Stock Shares Issued	6	5	3	2	207	0	2	2	1	4	1	1
Shares Outstanding	6	5	3	2	207	0	2	2	1	4	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	50.00%	6.00%	-11.00%	-	-	-	-	-	-	-	-	-
2025	-84.05%	-89.66%	-72.07%	-19.91%	-46.23%	-79.98%	23.88%	5.22%	-9.70%	1.04%	1.04%	-20.83%
2024	-29.58%	-43.31%	-42.96%	-26.90%	-37.24%	-56.55%	-7.32%	12.20%	-19.51%	12.00%	-24.91%	-82.39%
2023	-	-	-	-27.27%	-36.36%	3.64%	-39.11%	-53.11%	-34.00%	-19.27%	4.13%	-8.26%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	7.06	4.70	6.43	5.77	5.60	0.59	0.77	1.07	0.58	0.91	1.36	2.27
Quick Ratio	5.69	3.58	4.55	5.63	5.20	0.50	0.47	0.83	0.34	0.41	0.73	1.51
Working Capital	4.83M	4.92M	5.44M	3.62M	3.05M	-2.59M	-1.44M	521.00K	-3.52M	-717.00K	2.97M	8.55M
Leverage & Debt
Debt to Equity	0.12	0.20	0.15	0.21	0.22	-2.88	-6.55	7.20	-3.79	13.51	1.91	1.02
Interest Coverage TTM	-68.60	-135.92	-177.68	-207.30	-164.76	-176.53	-408.84	-673.47	-11,244.50	-	-	-
Debt Ratio	0.11	0.16	0.13	0.17	0.18	1.53	1.18	0.88	1.36	0.93	0.66	0.41
Efficiency & Turnover
Asset Turnover TTM	0.27	0.12	0.01	0.00	0.00	0.01	0.01	0.01	0.03	0.02	0.02	0.01
Days Sales Outstanding TTM	284.34	614.20	3,266.98	-	-	-	-	-	-	-	-	-
Receivables Turnover TTM	1.28	0.59	0.11	-	-	-	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-2.61	-6.45	-3.64	-	-22.85	-0.50	-300.60	-	-	-	-31.12	-28.39
Free Cash Flow Per Share TTM	-0.33	-2.18	-3.19	-5.51	-29.44	-0.36	-235.98	-6.38	-7.39	-3.65	-21.90	-24.27
Dividend Per Share TTM	0.01	0.03	0.02	0.03	0.00	0.00	1.12	0.06	0.15	0.06	0.38	0.36
Margin Metrics
Operating Profit Margin TTM	-292.39%	-1,128.11%	-10,309.88%	-95,360.00%	-84,735.71%	-27,916.28%	-20,994.59%	-25,255.00%	-5,008.69%	-6,060.24%	-7,439.07%	-7,656.84%
Net Profit Margin TTM	-932.98%	-1,886.48%	-8,585.19%	-64,080.00%	-59,621.43%	-26,074.42%	-18,150.00%	-21,882.50%	-4,386.86%	-5,370.24%	-6,350.39%	-6,371.85%
Growth Metrics
Net Revenue Growth (1Y)	10,792.86%	1,637.21%	9.46%	-87.50%	-96.88%	-89.76%	-80.98%	-78.55%	-	-	-	-
Net Income Growth (1Y)	70.46%	25.69%	-48.22%	-63.40%	-57.62%	-50.29%	-45.63%	-26.34%	-13.96%	6.40%	32.50%	28.23%
EPS Growth (1Y)	-88.59%	1,183.51%	-98.79%	-58.28%	52.95%	-90.17%	866.05%	-65.84%	-45.42%	-84.13%	10.63%	3.55%
Valuation Metrics
P/E TTM	-0.38	-0.23	-1.36	-1.22	-1.42	-87.62	-0.38	-19.36	-16.36	-60.51	-19.55	-36.12
P/B TTM	0.81	0.47	1.33	2.16	3.87	-451.90	-5.28	339.17	-146.09	2,248.53	112.38	128.68
P/S TTM	3.58	4.33	116.64	784.06	846.33	22,847.24	69.26	4,235.38	717.76	3,249.67	1,241.40	2,301.48
Market Cap	5.46M	3.23M	9.45M	7.84M	11.85M	982.43M	5.13M	338.83M	322.27M	1.36B	482.91M	858.45M
Enterprise Value	2.12M	-271.09K	5.61M	3.57M	8.40M	979.29M	2.14M	332.83M	322.27M	1.36B	476.96M	848.29M
Calculated Values
Free Cash Flow TTM	-1.80M	-4.77M	-6.09M	-8.73M	-10.75M	-7.99M	-10.54M	-11.51M	-9.74M	-16.12M	-17.38M	-20.32M
Net Debt	-3.34M	-3.51M	-3.84M	-4.28M	-3.45M	-3.14M	-2.98M	-6.00M	-2.00K	-3.38M	-5.94M	-10.16M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-05Sale

Owner: Yap, Kim Choy

Title: -

Shares: 28,540

Price/Share: $1.70

Value: $48,518.00

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Direct

2025-10-30Sale

Owner: Kua, Khai Loon

Title: -

Shares: 242,477

Price/Share: $1.80

Value: $436,458.60

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Direct

2025-10-30Sale

Owner: Ong, Yee Lung

Title: -

Shares: 248,814

Price/Share: $1.80

Value: $447,865.20

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Direct

2025-10-30Sale

Owner: Yap, Kim Choy

Title: -

Shares: 112,260

Price/Share: $1.81

Value: $203,190.60

Shares Owned: 28,500

Relationship: TenPercentOwner

Ownership: Direct

2025-10-29Sale

Owner: Yap, Kim Choy

Title: -

Shares: 110,749

Price/Share: $1.83

Value: $202,670.67

Shares Owned: 140,760

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-05	Yap, Kim Choy	TenPercentOwner	-	Direct	Sale	28,540	1.70	$48,518.00	0	4
2025-10-30	Kua, Khai Loon	TenPercentOwner	-	Direct	Sale	242,477	1.80	$436,458.60	0	4
2025-10-30	Ong, Yee Lung	TenPercentOwner	-	Direct	Sale	248,814	1.80	$447,865.20	0	4
2025-10-30	Yap, Kim Choy	TenPercentOwner	-	Direct	Sale	112,260	1.81	$203,190.60	28,500	4
2025-10-29	Yap, Kim Choy	TenPercentOwner	-	Direct	Sale	110,749	1.83	$202,670.67	140,760	4
2025-10-28	Yap, Kim Choy	TenPercentOwner	-	Direct	Sale	13,111	1.83	$23,993.13	251,509	4
2025-10-27	Yap, Kim Choy	TenPercentOwner	-	Direct	Sale	120,250	2.12	$254,930.00	264,620	4
2025-10-24	Ong, Yee Lung	TenPercentOwner	-	Direct	Sale	19,858	1.99	$39,517.42	248,814	4
2025-10-24	Yap, Kim Choy	TenPercentOwner	-	Direct	Sale	19,595	1.90	$37,230.50	384,870	4
2025-10-21	Fitters, Diversified Berh…	TenPercentOwner	-	Direct	Sale	92,352	3.01	$277,979.52	279,248	4
2025-10-20	Fitters, Diversified Berh…	TenPercentOwner	-	Direct	Sale	108,107	3.09	$334,050.63	371,600	4
2025-10-16	Fitters, Diversified Berh…	TenPercentOwner	-	Direct	Sale	26,051	5.50	$143,280.50	479,707	4
2025-10-16	Kua, Khai Loon	TenPercentOwner	-	Direct	Sale	88,204	4.22	$372,220.88	242,477	4
2025-10-14	Ong, Yee Lung	TenPercentOwner	-	Direct	Sale	135,793	6.00	$814,758.00	268,672	4
2025-10-10	Fitters, Diversified Berh…	TenPercentOwner	-	Direct	Sale	51,400	5.26	$270,364.00	505,758	4
2025-10-08	Fitters, Diversified Berh…	TenPercentOwner	-	Direct	Sale	142,000	5.29	$751,180.00	557,158	4
2025-09-16	Kua, Khai Loon	TenPercentOwner	-	Direct	Sale	25,000	5.13	$128,250.00	338,160	4
2025-09-05	Kua, Khai Loon	TenPercentOwner	-	Direct	Sale	19,054	7.01	$133,568.54	385,411	4
2025-07-30	Lazar, David E.	TenPercentOwner	-	Direct	Sale	6,750	12.36	$83,430.00	155,838	4
2025-02-26	Lazar, David E.	Officer,TenPercentOwner	Interim CEO	Direct	Sale	194,628,820	0.03	$5,838,864.60	0	4
2023-12-21	Rombotis, Spiro George	Director,Officer	President and CEO	Direct	Purchase	6,070	3.32	$20,152.40	68,658	4
2023-12-21	Mcbarron, Paul	Director,Officer	See Remarks	Direct	Purchase	1,886	3.32	$6,261.52	33,378	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

2.17%

Inst. Shares: 118,543

Shares Outstanding: 5,458,564

2025-12-31

3.62%

Inst. Shares: 79,038

Shares Outstanding: 2,185,075

2025-09-30

0.06%

Inst. Shares: 1,125

Shares Outstanding: 1,912,495

2025-06-30

71.82%

Inst. Shares: 262,316

Shares Outstanding: 365,231

2025-03-31

Inst. Shares: 1,626,479

Shares Outstanding: 365,231

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	118,543	5,458,564	2.17%
2025-12-31	79,038	2,185,075	3.62%
2025-09-30	1,125	1,912,495	0.06%
2025-06-30	262,316	365,231	71.82%
2025-03-31	1,626,479	365,231	-
2024-12-31	689,772	22,314,000	3.09%
2024-09-30	188,094	44,681	-
2024-06-30	204,354	44,681	-
2024-03-31	25,492	1,318,259	1.93%
2023-12-31	55,299	793,893	6.97%
2023-09-30	616,754	793,893	77.69%
2023-06-30	1,530,910	837,205	182.86%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Bio Green Med Solution, Inc. (BGMS) — SEC Financial Statements & Analysis

Bio Green Med Solution, Inc. (BGMS) is a pharmaceutical preparations company, incorporated in DE. Bio Green Med Solution, Inc. trades on Nasdaq, OTC as: BGMS, BGMSP. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bio Green Med Solution, Inc. reported a 10792.86% year-over-year revenue growth, a Debt-to-Equity ratio of 0.12x, a Price-to-Sales (P/S) ratio of 3.58x (TTM), a Price-to-Book (P/B) ratio of 0.81 (TTM), at a market cap of $5.46M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 10792.86%
Debt To Equity: 0.12x
P/S TTM: 3.58x
P/B TTM: 0.81
Market Cap: $5.46M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bio Green Med Solution, Inc. in?

Bio Green Med Solution, Inc. (BGMS) operates in the Pharmaceutical Preparations industry.

What is BGMS's market cap?

Bio Green Med Solution, Inc. (BGMS) has a market capitalization of $5.46M as of 2026-03-31.

What exchange does BGMS trade on?

Bio Green Med Solution, Inc. (BGMS) trades on the Nasdaq, OTC.

Where is Bio Green Med Solution, Inc. incorporated?

Bio Green Med Solution, Inc. is incorporated in DE.

Bio Green Med Solution, Inc. (BGMS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.